Related references
Note: Only part of the references are listed.Pharmacological Modulation of Nrf2/HO-1 Signaling Pathway as a Therapeutic Target of Parkinson's Disease
Yumin Wang et al.
FRONTIERS IN PHARMACOLOGY (2021)
Generation of New Isogenic Models of Huntington's Disease Using CRISPR-Cas9 Technology
Magdalena Dabrowska et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Pathogenesis of Mucopolysaccharidoses, an Update
Simona Fecarotta et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Plasma coenzyme Q10 status is impaired in selected genetic conditions
Raquel Montero et al.
SCIENTIFIC REPORTS (2019)
Oxidative and nitrative stress and pro-inflammatory cytokines in Mucopolysaccharidosis type II patients: effect of long-term enzyme replacement therapy and relation with glycosaminoglycan accumulation
Carlos Eduardo Diaz Jacques et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2016)
HEK293 in cell biology and cancer research: phenotype, karyotype, tumorigenicity, and stress-induced genome-phenotype evolution
A. A. Stepanenko et al.
GENE (2015)
Crosstalk between 2 organelles: Lysosomal storage of heparan sulfate causes mitochondrial defects and neuronal death in mucopolysaccharidosis III type C
Alexey V. Pshezhetsky
RARE DISEASES (2015)
Glycosaminoglycans can be associated with oxidative damage in mucopolysaccharidosis II patients submitted to enzyme replacement therapy
G. W. Negretto et al.
CELL BIOLOGY AND TOXICOLOGY (2014)
Mucopolysaccharidosis type II: Identification of 30 novel mutations among Latin American patients
A. C. Brusius-Facchin et al.
MOLECULAR GENETICS AND METABOLISM (2014)
Studying neurodegenerative diseases in culture models
Johannes C. M. Schlachetzki et al.
REVISTA BRASILEIRA DE PSIQUIATRIA (2013)
Genistein in Sanfilippo disease: A randomized controlled crossover trial
Jessica de Ruijter et al.
ANNALS OF NEUROLOGY (2012)
Improvement in the Range of Joint Motion in Seven Patients With Mucopolysaccharidosis Type II During Experimental Gene Expression-Targeted Isoflavone Therapy (GET IT)
Jolanta Marucha et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2011)
Oxidative stress in patients with mucopolysaccharidosis type II before and during enzyme replacement therapy
Leticia Filippon et al.
MOLECULAR GENETICS AND METABOLISM (2011)
DNA damage in leukocytes from pretreatment mucopolysaccharidosis type II patients; protective effect of enzyme replacement therapy
Leticia Filippon et al.
MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS (2011)
Genistein reduces glycosaminoglycan levels in a mouse model of mucopolysaccharidosis type II
A. Friso et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Concurrent measurement of unbound genistein in the blood, brain and bile of anesthetized rats using microdialysis and its pharmacokinetic application
TH Tsai
JOURNAL OF CHROMATOGRAPHY A (2005)
The cell biology of lysosomal storage disorders
AH Futerman et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2004)
Share Paper
